Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid (Q36303956)
scientific article
Language:
(P31) (Q13442814)
(P304) 150-157
(P433) 3
(P478) 2
(P577) Tuesday, March 1, 2005
(P1433) (Q15752073)
(P1476) "Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid" (language: en)
(P2093) William Kevin Kelly
Paul A Marks
(P2860) (Q55952250)
(Q80489191)
(Q44605584)
(Q31007797)
(Q35848270)
(Q41612134)
(Q45011782)
(Q44872972)
(Q41147554)
(Q22122355)
(Q22065840)
(Q34796349)
(Q53854384)
(Q36017473)
(Q35552110)
(Q53650118)
(Q33926323)
(Q24535587)
(Q56421597)
(Q35189383)
(Q40808976)
(Q27619648)
(Q24649964)
(Q35734509)
(Q24535620)
(Q52551084)
(Q41863296)
(Q24791823)
(Q29614886)
(Q40550020)
(Q33697130)
(Q35758280)
(Q43775906)
(Q40583269)
(P13046) (Q7318358)
other details
description scientific article

External Links